Expression of miR-26R in ovarian cancer tissues and analysis of its clinical significance.

Shi, W T; Peng, L N; Zhao, L J; Ma, X P

Shi, W T; Peng, L N; Zhao, L J; Ma, X P.

Afiliação

Shi WT; Department of Obstetrics and Gynecology, Liaocheng People's Hospital, Liaocheng, Shandong, China.
Peng LN; Department of Obstetrics and Gynecology, Liaocheng People's Hospital, Liaocheng, Shandong, China.
Zhao LJ; Department of Obstetrics and Gynecology, Liaocheng People's Hospital, Liaocheng, Shandong, China.
Ma XP; Department of Obstetrics and Gynecology, Liaocheng People's Hospital, Liaocheng, Shandong, China.

J Biol Regul Homeost Agents ; 33(4): 1221-1225, 2019.

Article em En | MEDLINE | ID: mdl-31328493

Assuntos

MicroRNAs/genética; Neoplasias Ovarianas/genética; Feminino; Regulação Neoplásica da Expressão Gênica; Humanos

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / MicroRNAs Limite: Female / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links